Kovack Advisors’s Oruka Therapeutics ORKA Stock Holding History

Kovack Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7	Closed	-$13K	–	255
2015 Q2	$13K	Buy	+7	New	+$9.2K	0.01%	201

Other funds holding ORKA

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kovack Advisors's ORKA Position: Q3 2015 in Review

Kovack Advisors sold out of Oruka Therapeutics (ORKA) in Q3 2015, closing a stake of 7 shares — an estimated $13K sold.

Kovack Advisors first reported a position in ORKA in Q2 2015 and held it in 1 quarter. The position peaked at $13K in Q2 2015. 13 funds tracked by Wall St. Rank hold ORKA as of Q3 2015.

Kovack Advisors reported no remaining Oruka Therapeutics position as of Q3 2015 after selling out during the quarter.
Kovack Advisors sold 7 Oruka Therapeutics shares in Q3 2015, an estimated $13K.
Kovack Advisors first reported a position in Oruka Therapeutics in Q2 2015 and held it in 1 quarter.
Kovack Advisors's Oruka Therapeutics position peaked at $13K in Q2 2015.
13 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2015.

Based on Kovack Advisors's 13F filing for Q3 2015, filed 29 Oct 2018.